Quick Takeaways
- Invus US Partners LLC has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $6,090,969.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Invus US Partners LLC
- Location
- New York, NY
- Summary
- The estimated value of insider holdings of Invus US Partners LLC is at least $6,090,969 dollars as of 09 Aug 2022. Invus US Partners LLC is the Director, 10%+ Owner of LEXICON PHARMACEUTICALS, INC. and owns shares of LEXICON PHARMACEUTICALS, INC. (LXRX) stock worth about $6.09M.
- Signature
- Invus US Partners LLC, By: /s/ Philip Bafundo , Name: Philip Bafundo, Title: Authorized Person
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Invus US Partners LLC and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: LEXICON PHARMACEUTICALS, INC. ($6,090,969).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Invus US Partners LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | $6,090,969 | 05 Aug 2022 |
Insider Transactions Reported by Invus US Partners LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.